1.对本次偏差涉及的博来霉素中间体样品进行重新检测。2.重新对阿糖胞苷

1. Re-test the bleomycin intermediate samples involved in this deviation. <br>2. Re-test the HPLC method verification-accuracy verification of Cytarabine A-3 and A-4 cleaning solution, and link the deviation number in the method verification report. <br>3. Change AIC102 host computer and AIC switch network connection port from 23# to 19#. <br>4. Post a prohibition mark on the network connection port 23# of the AIC switch.

1. The sample of Bollycomycin intermediates involved in this deviation is retredited.<br>2. Re-experiment on the verification-accuracy verification of the HPLC method of a glycosine A-3 and A-4 cleaning fluid, and link the deviation number in the method verification report.<br>3. Replace the AIC102 host network connection port with the AIC switch from 23 to 19.<br>4. Post a disabled logo on the AIC switch network connection port 23.

1. Retest the intermediate sample of bleomycin involved in this deviation.<br>2. The HPLC method validation accuracy validation of cytarabine A-3 and A-4 cleaning solution was tested again, and the deviation number was linked in the method validation report.<br>3. Change the network connection port between aic102 host and AIC switch from 23 to 19.<br>4. Post the disable sign on the network connection port 23 of AIC switch.